Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
If a year ago you had asked me what the prospects for a new public offering whose revenue stream was a same-sex hookup app, I probably wouldn’t have issued the typical Strong Buy recommendation, but – – proving life is stranger than fiction – – GRND continues to surge higher.
I first mentioned Oscar Health (OSCR) in February, and I’ve done about ten posts about it this year. It continues to do nicely, and on a day like this, I don’t even want to THINK about any shorts.
Below is the oddly-named Maplebear, which is actually Instacart. It’s a young stock, but the breakout is clear. The symbol, more logical than the company name, is CART.
Lord, what a brutal morning, huh? I’ve been trying to focus on the positive, which is (1) I was still at 35% cash (2) umm, let’s see, I don’t have cancer of the eyeballs.
I’ve made precious little changes to my portfolio, however, but I wanted to walk through those alterations. First, with a heavy heart, I got out of my EFA puts (January expiration). Candidly, I bet this chart ultimately works out fantastically, but I really needed to trim risk, so I ditched it.
I’ve spent a lifetime working with words, and the two that leap to mind right now would be “surprising” and, without a doubt, “discouraging.”
Yesterday evening, I had breathed a sigh of relief that not alone was the FOMC behind us, but that the rally that ensued had totally sputtered out. The rally got its second breath, however – – and a third, fourth, and fifth breath – – and blasted markets, thanks to the follow-through from overseas markets.
